All Stories

  1. From the International Association for the Study of Lung Cancer Early Detection and Screening Committee: Terminology Issues in Screening and Early Detection of Lung Cancer—International Association for the Study of Lung Cancer Early Detection and Scree...

    Article • Journal of Thoracic Oncology, August 2024, Elsevier

    Professor Rudolf M. Huber

  2. Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective

    Article • European Respiratory Review, January 2024, European Respiratory Society (ERS)

    Professor Rudolf M. Huber

  3. work-up of findings on screening CTs

    Article • Journal of Thoracic Oncology, November 2023, Elsevier

    Professor Rudolf M. Huber

  4. Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancer

    Article • Current Opinion in Oncology, October 2023, Wolters Kluwer Health

    Professor Rudolf M. Huber

  5. German S3 guideline about diagnosis, management, therapy and follow-up of lung cancer

    Article • Pneumologie, October 2023, Thieme Publishing Group

    Professor Rudolf M. Huber

  6. Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice

    Article • Journal of Cancer Research and Clinical Oncology, July 2023, Springer Science + Business Media

    Professor Rudolf M. Huber

  7. Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report

    Article • Journal of Thoracic Oncology, February 2022, Elsevier

    Professor Rudolf M. Huber

  8. Lung cancer screening. When is it appliccable in neversmokers?

    Article • Journal of Thoracic Oncology, January 2022, Elsevier

    Professor Rudolf M. Huber

  9. Progress in locally advanced non-small cell lung cancer

    Article • European Respiratory Review, May 2021, European Respiratory Society (ERS)

    Professor Rudolf M. Huber

  10. Multimodality management of locally advanced NSCLC

    Article • European Respiratory Review, June 2019, European Respiratory Society (ERS)

    Professor Rudolf M. Huber

  11. Daily Chronic Intermittent Hypobaric Hypoxia Does Not Induce Chronic Increase in Pulmonary Arterial Pressure Assessed by Echocardiography

    Article • Canadian Respiratory Journal, January 2018, Hindawi Publishing Corporation

    Frank Reichenberger, Professor Rudolf M. Huber

  12. P1.01-004 Hypertension With Brigatinib: Experience in ALTA, a Randomized Phase 2 Trial in Crizotinib-Refractory ALK+ NSCLC

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Professor Rudolf M. Huber

  13. EGFR mutations and EML4-ALK translocations in elderly patients with NSCLC

    Article • OncoTargets and Therapy, October 2017, Dove Medical Press

    Professor Rudolf M. Huber

  14. Cancer vaccination causes prolonged FDG accumulation in subcutaneous tissue

    Article • Nuklearmedizin - NuclearMedicine, April 2017, Schattauer GmbH

    Professor Rudolf M. Huber

  15. Metronomic therapy of NSCLC with vinorelbine

    Article • OncoTargets and Therapy, February 2017, Dove Medical Press

    Dr. Birgit Edlich, Professor Rudolf M. Huber

  16. European curriculum for Thoracic Oncology

    Article • Breathe, August 2016, European Respiratory Society (ERS)

    Professor Rudolf M. Huber

  17. Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2015, Dove Medical Press

    Professor Rudolf M. Huber

  18. Thoracic Oncology HERMES: a European syllabus towards a harmonised education and training of Thoracic Oncology specialists

    Article • Breathe, September 2013, European Respiratory Society (ERS)

    Professor Rudolf M. Huber

  19. Thoracic Oncology HERMES syllabus: setting the basis for thoracic oncology training in Europe: Table 1–

    Article • European Respiratory Journal, September 2013, European Respiratory Society (ERS)

    Professor Rudolf M. Huber

  20. Can MicroRNAs Improve the Management of Lung Cancer Patients? A Clinician's Perspective

    Article • Theranostics, January 2013, Ivyspring International Publisher

    Professor Rudolf M. Huber

  21. Diatnosis and treatment of small cell lung cancer

    Article • Breathe, June 2012, European Respiratory Society (ERS)

    Professor Rudolf M. Huber

  22. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summary

    Article • Proceedings of the American Thoracic Society, September 2011, American Thoracic Society

    Dr CHARLES A POWELL, Professor Rudolf M. Huber

  23. Reduced expression of bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance

    Article • European Journal of Medical Research, January 2010, Springer Science + Business Media

    Professor Rudolf M. Huber

  24. Mukoziliäre Funktion bei Mukoviszidose

    Article • Pneumologie, December 2007, Thieme Publishing Group

    Professor Rudolf M. Huber

  25. Screening des Lungenkarzinoms - aktueller Stand

    Article • Pneumologie, March 2005, Thieme Publishing Group

    Professor Rudolf M. Huber

  26. Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol®) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer

    Article • Lung Cancer, May 2001, Elsevier

    Professor Rudolf M. Huber

  27. Maximal inspiratory mouth pressures (PIMAX) in healthy subjects—what is the lower limit of normal?

    Article • Respiratory Medicine, July 2000, Elsevier

    Professor Rudolf M. Huber